Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a global leader in minimally invasive Microwave Ablation (MWA) technology, has successfully concluded its participation in the American College of Surgeons (ACS) Clinical Congress 2025, held from October 5-7. The event served as a key platform for showcasing the Company's innovative technology to […]